ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers

June 28, 1991

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

July 10, 1992

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

ACCC Asks More Community Representation, Clear Separation From Centers In New NCI Division

June 29, 1979

Tobacco Council Grants Total 3,348

July 15, 1988